Literature DB >> 27059231

Inhibition of MicroRNA-221 Alleviates Neuropathic Pain Through Targeting Suppressor of Cytokine Signaling 1.

Li Xia1, Yunlong Zhang2, Tieli Dong3.   

Abstract

Neuropathic pain results in considerable trouble to people's physical and mental health. The pathophysiological mechanisms underlying its occurrence and development remain unclear. A large number of experiments show that microRNAs (miRNAs) play a major role in the pathogenesis of neuropathic pain and neuroinflammation resulting from nerve injury. Among various miRNAs, microRNA-221 (miR-221) overexpression has been reported in a chronic constrictive injury (CCI)-induced rat model of neuropathic pain. However, the role of miR-221 in the regulation of neuropathic pain is unknown. In this study, we investigated the potential role and underlying mechanism of miR-221 in regulating neuropathic pain. Our findings show that miR-221 is overexpressed in the spinal cord and the isolated microglia of CCI rats. Intrathecal injection of a miR-221 inhibitor attenuated CCI-induced mechanical allodynia and thermal hyperalgesia, and reduced proinflammatory cytokine expression, including tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 in CCI rats. Using a dual-luciferase reporter assay, we show that suppressor of cytokine signaling 1 (SOCS1), an important regulator of inflammation, is a direct target of miR-221. Treatment with the miR-221 inhibitor significantly inhibited the expression of SOCS1. Furthermore, the miR-221 inhibitor markedly suppressed the activation of nuclear factor-kappa B (NF-κB) and the p38 mitogen-activated protein kinase (p38 MAPK) signaling pathway. Knockdown of SOCS1 in CCI rats abrogated the inhibitory effect of the miR-221 inhibitor on CCI-induced neuropathic pain and the NF-κB and p38 MAPK signaling pathways. Together, these results suggest that inhibition of miR-221 alleviates neuropathic pain and neuroinflammation through increasing SOCS1 and by inhibiting the NF-κB and p38 MAPK signaling pathways, indicating that miR-221 may be a promising molecular target for the treatment of neuropathic pain.

Entities:  

Keywords:  Inflammatory response; Neuropathic pain; Suppressor of cytokine signaling 1; miR-221

Mesh:

Substances:

Year:  2016        PMID: 27059231     DOI: 10.1007/s12031-016-0748-1

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  38 in total

1.  Comparison of actions of systemically and locally administrated local anaesthetics in diabetic rats with painful neuropathy.

Authors:  Tufan Mert; Yasemin Gunes; Ismail Gunay
Journal:  Fundam Clin Pharmacol       Date:  2011-10-11       Impact factor: 2.748

Review 2.  MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions.

Authors:  Hjalte H Andersen; Meg Duroux; Parisa Gazerani
Journal:  Neurobiol Dis       Date:  2014-08-10       Impact factor: 5.996

3.  JAK-STAT3 pathway regulates spinal astrocyte proliferation and neuropathic pain maintenance in rats.

Authors:  Makoto Tsuda; Yuta Kohro; Takayuki Yano; Tomoko Tsujikawa; Junko Kitano; Hidetoshi Tozaki-Saitoh; Satoru Koyanagi; Shigehiro Ohdo; Ru-Rong Ji; Michael W Salter; Kazuhide Inoue
Journal:  Brain       Date:  2011-03-02       Impact factor: 13.501

4.  Lentiviral-mediated targeted NF-kappaB blockade in dorsal spinal cord glia attenuates sciatic nerve injury-induced neuropathic pain in the rat.

Authors:  Alice Meunier; Alban Latrémolière; Elisa Dominguez; Annie Mauborgne; Stéphanie Philippe; Michel Hamon; Jacques Mallet; Jean-Jacques Benoliel; Michel Pohl
Journal:  Mol Ther       Date:  2007-02-13       Impact factor: 11.454

5.  MiR-19a targets suppressor of cytokine signaling 1 to modulate the progression of neuropathic pain.

Authors:  Conghui Wang; Qi Jiang; Min Wang; Dong Li
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

6.  Quantitative assessment of tactile allodynia in the rat paw.

Authors:  S R Chaplan; F W Bach; J W Pogrel; J M Chung; T L Yaksh
Journal:  J Neurosci Methods       Date:  1994-07       Impact factor: 2.390

7.  PNA-based microRNA inhibitors elicit anti-inflammatory effects in microglia cells.

Authors:  Peter N Brown; Hang Yin
Journal:  Chem Commun (Camb)       Date:  2012-10-31       Impact factor: 6.222

8.  Suppressor of cytokine signaling 1 protects mice against concanavalin A-induced hepatitis by inhibiting apoptosis.

Authors:  Takehiro Torisu; Mako Nakaya; Satoko Watanabe; Masayuki Hashimoto; Hideyuki Yoshida; Takatoshi Chinen; Ryoko Yoshida; Fuyuki Okamoto; Toshikatsu Hanada; Kumiko Torisu; Giichi Takaesu; Takashi Kobayashi; Hideo Yasukawa; Akihiko Yoshimura
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

9.  MicroRNA-146a-5p attenuates neuropathic pain via suppressing TRAF6 signaling in the spinal cord.

Authors:  Ying Lu; De-Li Cao; Bao-Chun Jiang; Tian Yang; Yong-Jing Gao
Journal:  Brain Behav Immun       Date:  2015-05-05       Impact factor: 7.217

10.  SOCS, Inflammation, and Autoimmunity.

Authors:  Akihiko Yoshimura; Mayu Suzuki; Ryota Sakaguchi; Toshikatsu Hanada; Hideo Yasukawa
Journal:  Front Immunol       Date:  2012-03-12       Impact factor: 7.561

View more
  19 in total

1.  MiR-183-5p Alleviates Chronic Constriction Injury-Induced Neuropathic Pain Through Inhibition of TREK-1.

Authors:  Dan-Ni Shi; Yi-Tao Yuan; Dan Ye; Lu-Mei Kang; Jing Wen; Hong-Ping Chen
Journal:  Neurochem Res       Date:  2018-05-07       Impact factor: 3.996

2.  Inhibition of miR-221 alleviates LPS-induced acute lung injury via inactivation of SOCS1/NF-κB signaling pathway.

Authors:  Tao Wang; Lihua Jiang; Xiaoyong Wei; Zhenghua Dong; Bo Liu; Junbo Zhao; Lijuan Wang; Peilin Xie; Yuxia Wang; Shangyou Zhou
Journal:  Cell Cycle       Date:  2019-07-11       Impact factor: 4.534

3.  The Role of MicroRNAs in Patients with Amyotrophic Lateral Sclerosis.

Authors:  Efthimios Dardiotis; Athina-Maria Aloizou; Vasileios Siokas; George P Patrinos; Georgia Deretzi; Panayiotis Mitsias; Michael Aschner; Aristidis Tsatsakis
Journal:  J Mol Neurosci       Date:  2018-11-10       Impact factor: 3.444

Review 4.  MicroRNAs in the Spinal Microglia Serve Critical Roles in Neuropathic Pain.

Authors:  Simin Tang; Huan Jing; Fuhu Song; Haicheng Huang; Wenjun Li; Guiling Xie; Jun Zhou
Journal:  Mol Neurobiol       Date:  2020-09-09       Impact factor: 5.590

Review 5.  Interactions Among lncRNAs/circRNAs, miRNAs, and mRNAs in Neuropathic Pain.

Authors:  Ge Song; Zheng Yang; Jiabao Guo; Yili Zheng; Xuan Su; Xueqiang Wang
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

Review 6.  Bioinformatics Genes and Pathway Analysis for Chronic Neuropathic Pain after Spinal Cord Injury.

Authors:  Guan Zhang; Ping Yang
Journal:  Biomed Res Int       Date:  2017-10-15       Impact factor: 3.411

7.  Micro-RNAs in ALS muscle: Differences in gender, age at onset and disease duration.

Authors:  Valentina Pegoraro; Antonio Merico; Corrado Angelini
Journal:  J Neurol Sci       Date:  2017-07-06       Impact factor: 3.181

Review 8.  Recent advances in understanding neuropathic pain: glia, sex differences, and epigenetics.

Authors:  Halina Machelska; Melih Ö Celik
Journal:  F1000Res       Date:  2016-11-22

9.  Activation of dorsal horn cannabinoid CB2 receptor suppresses the expression of P2Y12 and P2Y13 receptors in neuropathic pain rats.

Authors:  Juan Niu; Dujuan Huang; Rui Zhou; MingXia Yue; Tao Xu; Junna Yang; Li He; Hong Tian; XiaoHong Liu; Junwei Zeng
Journal:  J Neuroinflammation       Date:  2017-09-12       Impact factor: 8.322

Review 10.  Epigenetic Modifications Associated to Neuroinflammation and Neuropathic Pain After Neural Trauma.

Authors:  Clara Penas; Xavier Navarro
Journal:  Front Cell Neurosci       Date:  2018-06-07       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.